tirzepatide surmount 3 after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase trial - Nature Medicine Semaglutide vs. Tirzepatide for Obesity
Description
113 It was then fused to the constant region (Fc) of modified human immunoglobulin G4 (IgG4) via a -(Gly-Gly-Gly-Gly-Ser) 3-Ala- bridge and exhibits an average biological half-life of 90 h
Additionally, the recommended injection sitesthe abdomen, the front of the thighs, and the back of the upper armare chosen specifically because they are fat-rich areas with very few large, superficial veins
This is precisely why generic advice like "draw 20 units" without specifying the concentration is meaningless and potentially harmful
Diabetes Ther (2021) 12(1):5570
Ledford, H
